Medical Professionals Reference (MPR)Family Sues Doctors Following Noncompliant Patient’s Death

A widow sued two physicians and a hospital after her husband died of pulmonary embolism one day after taking his only rivaroxaban dose following repeated noncompliance warnings. An appellate court upheld the jury’s defense verdict, confirming thorough documentation and signed acknowledgment can defeat noncompliance-based malpractice claims.

Why It Matters

• Despite unanimous jury verdict for defense, plaintiff pursued JNOV and appeal; the documented noncompliance alone does not end litigation
• One prescription error (missing dosage frequency) nearly derailed the defense; a pharmacist correction resolved it, but the gap created legal exposure
• Appeals court confirmed juries may rule for defendants when evidence shows patient-initiated noncompliance as the proximate cause of harm
• Case involved two separate physicians across two hospitals so liability tracked the prescribing clinician, not the institution

What to Watch

• Signed written acknowledgment is now the clearest differentiator between defensible and indefensible noncompliance cases
• Prescription specificity (dose, frequency, route) must be explicit; pharmacist corrections after the fact still create a documented gap prosecutors can exploit
• Alcohol-drug interaction warnings should be charted explicitly and separately, not bundled into general discharge instructions
• Courts are increasingly willing to let noncompliance cases reach trial — motions to dismiss are not reliable early exits

More in Malpractice